Profile data is unavailable for this security.
About the company
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
- Revenue in USD (TTM)31.84m
- Net income in USD-8.93m
- Incorporated1989
- Employees82.00
- LocationCryo-Cell International Inc700 BROOKER CREEK BLVD, SUITE 1800OLDSMAR 34677United StatesUSA
- Phone+1 (813) 749-2104
- Fax+1 (813) 855-4745
- Websitehttps://www.cryo-cell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychemedics Corp. | 20.26m | -3.00m | 13.79m | 116.00 | -- | 2.53 | -- | 0.6809 | -0.5142 | -0.5142 | 3.47 | 0.9238 | 1.69 | -- | 5.12 | 174,637.90 | -25.02 | -7.44 | -40.58 | -9.70 | 38.36 | 37.55 | -14.78 | -6.26 | -- | -292.90 | 0.0969 | -- | -12.45 | -12.33 | -283.21 | -- | -33.32 | -- |
| PharmChem Inc | 6.00m | 1.27m | 14.64m | 170.00 | 11.55 | 4.73 | 11.53 | 2.44 | 0.2727 | 0.2727 | 1.29 | 0.6661 | 1.67 | 7.23 | 8.04 | -- | 35.37 | -- | 44.59 | -- | 64.09 | -- | 21.17 | -- | 4.45 | -- | 0.00 | -- | 3.50 | -- | -16.95 | -- | -- | -- |
| Concord Medical Services Hldgs Ltd (ADR) | 65.10m | -52.30m | 18.24m | 727.00 | -- | -- | -- | 0.2801 | -11.97 | -11.97 | 14.90 | -67.98 | 0.0743 | 13.39 | 5.35 | 89,544.35 | -10.23 | -9.49 | -111.95 | -39.24 | -17.13 | -15.06 | -137.67 | -134.56 | 0.4556 | -1.89 | 0.6369 | -- | 13.84 | 23.00 | 39.21 | -- | -6.88 | -- |
| ProPhase Labs Inc | 12.75m | -27.76m | 18.26m | 113.00 | -- | 0.3828 | -- | 1.43 | -1.50 | -1.50 | 0.6887 | 2.00 | 0.139 | 3.74 | 0.3629 | 112,858.40 | -30.25 | 0.9106 | -40.11 | 1.12 | -32.38 | 50.32 | -217.64 | 0.9325 | 1.33 | -12.78 | 0.2837 | 665.78 | -63.81 | 27.59 | -190.90 | -- | 86.46 | -- |
| Elite Health Systems Inc | 0.00 | -1.18m | 21.73m | 2.00 | -- | 5.94 | -- | -- | -0.0938 | -0.0938 | 0.00 | 0.2106 | 0.00 | -- | -- | 0.00 | -45.56 | -14.62 | -49.63 | -19.89 | -- | -- | -- | -36.77 | -- | -- | 0.00 | -- | -- | -- | 38.97 | -- | -- | -- |
| Burning Rock Biotech Ltd (ADR) | 70.36m | -78.22m | 47.60m | 786.00 | -- | 0.5081 | -- | 0.6766 | -48.55 | -48.55 | 12.47 | 9.13 | 0.4331 | 1.97 | 2.68 | 89,513.99 | -48.15 | -37.09 | -65.09 | -45.29 | 67.71 | 70.02 | -111.18 | -123.88 | 2.85 | -- | 0.00 | -- | -4.58 | 20.81 | 32.69 | -- | -17.61 | -- |
| CRYO-CELL International, Inc. | 31.84m | -8.93m | 63.45m | 82.00 | -- | -- | -- | 1.99 | -1.08 | -1.08 | 3.86 | -1.19 | 0.4798 | 9.35 | 4.78 | 388,274.30 | -13.45 | 0.4686 | -18.45 | 0.7099 | 73.66 | 70.09 | -28.04 | 0.8133 | 0.5699 | -- | -- | -- | 3.32 | 1.41 | -443.57 | -- | 60.30 | -- |
| Exagen Inc | 55.75m | -16.93m | 73.02m | 174.00 | -- | 5.72 | -- | 1.31 | -0.9383 | -0.9383 | 3.09 | 0.7345 | 1.07 | -- | 4.22 | 320,408.00 | -32.39 | -30.21 | -39.53 | -33.75 | 58.80 | 54.86 | -30.36 | -55.36 | -- | -6.88 | 0.6148 | -- | 15.33 | 10.13 | 50.01 | -- | 33.00 | -- |
| 23andMe Holding Co. | 193.26m | -615.31m | 75.91m | 560.00 | -- | 0.7984 | -- | 0.3928 | -25.27 | -25.27 | 7.84 | 3.95 | 0.3451 | 6.93 | 198.52 | 345,107.20 | -109.86 | -- | -142.15 | -- | 46.51 | 46.35 | -318.39 | -121.63 | 1.14 | -- | 0.00 | -- | -26.66 | -13.01 | -113.92 | -- | -19.09 | -- |
| Cardiff Lexington Corp | 7.22m | -2.84m | 97.74m | 10.00 | 0.7895 | -- | -- | 13.54 | 8.23 | 3.61 | 0.9605 | 0.5838 | 0.3436 | -- | 0.542 | 722,096.00 | -9.27 | -- | -25.14 | -- | 49.32 | 62.01 | -26.98 | -- | -- | -0.0099 | 0.4916 | -- | -- | 39.71 | -- | -- | -- | -- |
| American Well Corp | 254.04m | -214.08m | 120.11m | 1.10k | -- | 0.356 | -- | 0.4728 | -14.54 | -14.54 | 17.22 | 22.02 | 0.4545 | 26.31 | 3.74 | 230,104.20 | -38.46 | -28.25 | -49.63 | -32.66 | 34.80 | 40.51 | -84.63 | -121.27 | 2.88 | -- | 0.00 | -- | -6.55 | 17.85 | -149.66 | -- | 51.49 | -- |
Data as of Nov 22 2024. Currency figures normalised to Cryo-Cell International Inc's reporting currency: US Dollar USD
6.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SFI Advisors LLCas of 30 Sep 2024 | 165.30k | 2.05% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 116.85k | 1.45% |
| MML Investors Services LLCas of 30 Sep 2024 | 111.04k | 1.38% |
| Geode Capital Management LLCas of 30 Sep 2024 | 39.86k | 0.49% |
| Cerity Partners LLCas of 30 Sep 2024 | 19.56k | 0.24% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2024 | 13.72k | 0.17% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 12.50k | 0.16% |
| Northern Trust Global Investments Ltd.as of 30 Sep 2024 | 8.11k | 0.10% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2024 | 2.00k | 0.03% |
| BlackRock Investment Management LLCas of 30 Sep 2024 | 1.16k | 0.01% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
